Real-life safety assessment of orally disintegrating desmopressin tablet: Incidence of diagnosed hyponatraemia and other events across three European countries.

Johansson G, Reinold J, Shapero NL, Rosell TL, Jørgensen LA, Koenen N, Frøsig C, Falkenberg M, Holdrup L, Juul K

Open source

DOI
10.1016/j.gloepi.2025.100228
Published
2025 Dec
Container
Global epidemiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.gloepi.2025.100228,
  title = {Real-life safety assessment of orally disintegrating desmopressin tablet: Incidence of diagnosed hyponatraemia and other events across three European countries.},
  author = {Johansson G and Reinold J and Shapero NL and Rosell TL and Jørgensen LA and Koenen N and Frøsig C and Falkenberg M and Holdrup L and Juul K},
  year = {2025},
  journal = {Global epidemiology},
  doi = {10.1016/j.gloepi.2025.100228},
  url = {https://doi.org/10.1016/j.gloepi.2025.100228}
}

RIS

TY  - JOUR
TI  - Real-life safety assessment of orally disintegrating desmopressin tablet: Incidence of diagnosed hyponatraemia and other events across three European countries.
AU  - Johansson G
AU  - Reinold J
AU  - Shapero NL
AU  - Rosell TL
AU  - Jørgensen LA
AU  - Koenen N
AU  - Frøsig C
AU  - Falkenberg M
AU  - Holdrup L
AU  - Juul K
PY  - 2025
JO  - Global epidemiology
DO  - 10.1016/j.gloepi.2025.100228
UR  - https://doi.org/10.1016/j.gloepi.2025.100228
ER  - 

APA

G, J., J, R., NL, S., TL, R., LA, J., N, K., C, F., M, F., L, H., & K, J. (2025). Real-life safety assessment of orally disintegrating desmopressin tablet: Incidence of diagnosed hyponatraemia and other events across three European countries.. Global epidemiology. https://doi.org/10.1016/j.gloepi.2025.100228

Source records